This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
18F-Fludeoxyglucose (18F-FDG); Sterility concerns
Last updated
Summary
Product
18F-Fludeoxyglucose (18F-FDG)
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|---|
| Isologic Innovative Radiopharmaceuticals | 18F-FLUDEOXYGLUCOSE (18F-FDG) | DIN 02328739 | Solution | Fludeoxyglucose 18F 7400 MBq / mL | L06DEC22-4 |
Issue
Product sterility may be compromised in the affected lot.
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Healthcare Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs - Radiopharmaceuticals
Companies
Isologic Innovative Radiopharmaceuticals Inc.
1855 32e Avenue,
Lachine, QC, H8T 3J1, Canada
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-72366
Get notified
Receive notifications for new and updated recalls and alerts by category.